Richmond, Canada Clinical Trials

A listing of Richmond, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy

This trial is designed to assess the efficacy of a novel carbon-fibre adjustable reusable accessory (CARA) for breast support to reduce skin toxicity and unwanted normal tissue dose in comparison to the current clinical standard for supine breast support during whole breast RT.

BC Cancer
 (6.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D[s]) and maximum tolerated dose (MTD) of JNJ-70218902 in Part 1, and to determine the safety of JNJ-70218902 RP2D(s) in Part 2.

adenocarcinoma
targeted therapy
gnrh
castration-resistant prostate cancer
gonadotropin releasing hormone
BC Cancer Agency - Vancouver BC
 (6.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
tirzepatide
cardiovascular disease
dulaglutide
Dr. T.G. Elliott, Inc.
 (6.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
High Dose Accelerated iTBS for Depression

This trial will compare active intermittent theta burst stimulation (iTBS) rTMS in an accelerated treatment schedule (8 treatment sessions per day for 5 days) to a placebo control. Depression symptom severity will be measured before, during, at end of treatment, 1-week post and 4-weeks post treatment.

treatment regimen
antidepressants
depression
psychotropic drugs
transcranial magnetic stimulation
University of British Columbia
 (8.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

This study will investigate the effects of atezolizumab on select cancer types in people whose analysis of tumour DNA and RNA indicates they may be sensitive to atezolizumab. This study aims to determine if the information from the cancer genome analysis corresponds with the effects of atezolizumab on individuals and …

international normalized ratio
head and neck cancer
neutrophil count
transcriptome analysis
platelet count
BC Cancer
 (6.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. …

cell-free dna
blood test
hereditary cancer syndromes
cancer
hereditary cancer
BC Cancer Agency
 (6.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
myoActivation for Chronic Pain in a Marginalized Population

Marginalized populations are at increased risk of chronic pain, trauma and use of street drugs to manage this suffering, with the associated risk of overdoses. Non-pharmacological options to manage chronic pain are difficult for this population to access. myoActivation is an innovative structured assessment and therapeutic approach. This study will …

drug overdose
chronic pain
street drugs
Vancouver Community Pain Service, 524 East Pender Street
 (8.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location